Letter to the Editor
Optimizing the use of systemic corticosteroids in severe asthma (ROSA II project): a national Delphi consensus study
J. Marques1,a,b,
, F. Duarte-Ramos1,c,d, M.B. Ferreirae,f, R. Limag, C. Lopesh, A. Sokolovai, F.S. Toninj,k, C.C. Loureirol,m, Portuguese ROSA Group
Corresponding author
a Immunology and Allergy Department, Centro Hospitalar e Universitário de Lisboa Central, EPE, Lisboa, Portugal
b CEDOC, Integrated Pathophysiological Mechanisms Research Group, Lisboa, Portugal
c Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, University of Lisboa, Lisboa, Portugal
d EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Portugal
e Serviço de Imunoalergologia, Centro Hospitalar de Lisboa Norte, Lisboa, Portugal
f Clínica Universitária de Imunoalergologia, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
g Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
h Departamento do Tórax, Hospital de Santa Maria, Lisbon, Portugal
i Immunology and Allergy Department, Hospital Prof. Doutor Fernando Fonseca, EPE, Amadora, Portugal
j ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal
k H&TRC - Health & Technology Research Center, Instituto Politécnico de Lisboa, Lisbon, Portugal
l Pulmonology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Portugal
m Centre of Pulmonology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
Ver más
